Want to see JP:4569 full AI Analyst Report?
KYORIN Pharmaceutical Co.,Ltd. (4569) Revenue
3 Followers
KYORIN Pharmaceutical Co.,Ltd. Revenue
KYORIN Pharmaceutical Co.,Ltd. had a revenue of 29.65B in the quarter ending Jun 30, 2026, with -12.27%. This bring the company's revenue in the last twelve months to 125.68B, Decreased 0.46%. In the fiscal year ending Mar 31, 2026, KYORIN Pharmaceutical Co.,Ltd. had annual revenue of 126.26B with -2.94% growth.
- Revenue (ttm)
- 125.68B
- Revenue Growth
- -4.71%
- P/S Ratio
- 0.46
- Revenue/Employee
- JPY 63,701,816
- Employees
- 1,982
- Market Cap
- JPY 58.22B
Revenue Chart
KYORIN Pharmaceutical Co.,Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 126.26B | -3.83B | -2.94% |
| Mar 31, 2025 | 130.09B | 10.55B | 8.83% |
| Mar 31, 2024 | 119.53B | 6.26B | 5.53% |
| Mar 31, 2023 | 113.27B | 7.74B | 7.33% |
| Mar 31, 2022 | 105.53B | 2.63B | 2.56% |
| Mar 31, 2021 | 102.90B | -7.08B | -6.44% |
| Mar 31, 2020 | 109.98B | -3.64B | -3.20% |
| Mar 31, 2019 | 113.62B | 2.98B | 2.69% |
| Mar 31, 2018 | 110.64B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.